Thiourea

Thiourea

SCHEMBL5430249

N=C=S.NC(N)=S

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiourea SCHEMBL8657126 0.86
Guanidine SCHEMBL29044101 0.82 TSHR (0.31)
Guanidine SCHEMBL1903839 0.82 TSHR (0.31)
Guanidine SCHEMBL56028 0.82
Thiourea SCHEMBL9095544 0.80
Guanidine SCHEMBL6851202 0.78
Thiourea SCHEMBL18528963 0.78 TSHR (0.50)
Guanidine SCHEMBL7755519 0.78
Guanidine SCHEMBL31206959 0.78
Thiourea SCHEMBL5421224 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105732535-B A kind of improved azilide compound and its preparation method and application 中国农业大学 2019-03-19 CN claimed
WO-2024030954-A1 CHEMICAL MODIFICATION OF ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF NAUTILUS SUBSIDIARY, INC. (US) 2024-02-08 WO disclosed
WO-2023102336-A1 PARTICLE-BASED ISOLATION OF PROTEINS AND OTHER ANALYTES NAUTILUS SUBSIDIARY, INC. (US) 2023-06-08 WO disclosed
CN-101454004-A Pyridone sulfonamides and pyridone sulfamides as mek inhibitors ARDEA BIOSCIENCES INC (US) 2009-06-10 CN disclosed
US-7214762-B1 Redox-active polymer and electrode comprising the same JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2007-05-08 US disclosed
US-5166180-A Administering diphenyl substituted (thio)carbonyl(thio)urea derivatives DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1992-11-24 US disclosed
EP-0324521-A2 Method of treating haematologic diseases and pharmaceutical compositions to be used therefor DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1989-07-19 EP disclosed